INSIST! Prostate Cancer
June 2026
Insist! on Better Care
Biomarker testing in Prostate Cancer is essential to ensure patients are receiving the best, most personalized care available. The goal of INSIST! Prostate Cancer is to educate and empower patients and care partners to speak up and insist on better care.
Program topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding Prostate Cancer Testing


Self-Advocacy | Why In-Depth Cancer Testing Is Essential
December 5, 2025

Molecular Testing and Hereditary Testing: What’s the Difference?
December 5, 2025

When Should Someone With Cancer Undergo Molecular Testing?
November 6, 2025

What Is Molecular Testing and Why Is It Necessary in Cancer Care?
November 6, 2025

Common Symptoms of Advanced Prostate Cancer
September 27, 2023






Essential Testing Following a Prostate Cancer Diagnosis
April 12, 2023

Could Genetic Mutations Impact Your Prostate Cancer Treatment Options?
September 30, 2021

What Do Prostate Cancer Patients Need to Know About Genetic Testing?
September 30, 2021


Understanding Prostate Cancer Staging and Progression
August 6, 2021


What Is a Prostate Cancer Genetic Mutation?
June 24, 2021

What Is a Prostate Cancer Biomarker?
June 24, 2021
Prostate Cancer Treatment Decisions


Evolving Research | Advanced Prostate Cancer Treatment
September 27, 2023


How Is Advanced Prostate Cancer Treatment Personalized?
September 27, 2023


What Are Current Prostate Cancer Treatment Options?
July 31, 2023

Prostate Cancer Clinical Trials: What Are the Benefits?
July 31, 2023






Prostate Cancer Treatment: What Is Precision Oncology?
April 12, 2023


How Does Genetic Testing Impact Prostate Cancer Care?
August 6, 2021

Treatment Options for Advanced Prostate Cancer
August 6, 2021

Prostate Cancer Treatment and Research News
August 6, 2021


INSIST! Prostate Cancer Resources

INSIST! Prostate Cancer Conversation Guide
July 20, 2026

INSIST! Prostate Cancer Resource Guide
November 10, 2023



This program is supported by Clovis Oncology, Exact Sciences, Foundation Medicine, Janssen, Merck, Pfizer, Sumitomo Pharma and through generous donations from people like you.